Drug Profile
Avatrombopag - Swedish Orphan Biovitrum
Alternative Names: AKR-501; AKR-501 monomaleate; Avatrombopag maleate; DOPTELET; E-5501; Su Ke Xin; YM-477Latest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Developer Dova Pharmaceuticals; Eisai Co Ltd; Shanghai Fosun Pharmaceutical; Swedish Orphan Biovitrum
- Class Antithrombotics; Piperazines; Piperidines; Pyridines; Small molecules; Thiazoles
- Mechanism of Action Thrombopoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Thrombocytopenia
- Registered Idiopathic thrombocytopenic purpura
Most Recent Events
- 08 Jun 2023 Phase-III clinical trials in Idiopathic thrombocytopenic purpura in China (PO)
- 08 Jun 2023 Efficacy and safety data from a phase III trial in Idiopathic thrombocytopenic purpura presented at the 28th Congress of the European Haematology Association 2023 (EHA-2023)
- 27 Mar 2023 Registered for Thrombocytopenia in Japan (PO)